Reliable diagnostics are crucial

                         in the response to the outbreak

EyeRa   COVID 19 (under development)

EyeRa  COVID 19 is a next generation diagnostic kit developed on our patent granted technology with sensitivity 1000-10000X over conventional ELISA when read on our state of the art CE compliant SPR device. It has been test license granted by CDSCO for test evaluation.

1. Detect antigen at a picogram/ml concentration

2. Assay time just 5 minutes
3. Cost effective 30 times lower antibody requirement than conventional ELISA
4. Sensitivity 1000-10000X times higher than conventional ELISA
5. Simple work flow

Our EyeRa COVID 19 will be soon ready to fight the war against this Pandemic. But we also want arm other warriors as well. Scientists and manufacturers around the world, those are working at breakneck speed to figure out how to detect, treat, and control the coronavirus. We open our all reagent resources.